New hope for older leukemia patients: drug may keep cancer away after transplant
NCT ID NCT03286530
First seen Mar 31, 2026 · Last updated May 20, 2026 · Updated 7 times
Summary
This study tests whether the drug ruxolitinib can help prevent acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) from coming back after a stem cell transplant. It includes older adults whose cancer is in remission. The goal is to improve survival and reduce complications like graft-versus-host disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02115, United States
-
Medical College of Wisconsin
Wauwatosa, Wisconsin, 53226, United States
-
The Ohio State University
Columbus, Ohio, 43210, United States
-
Vanderbilt University
Nashville, Tennessee, 37235, United States
-
Washington University
St Louis, Missouri, 63130, United States
Conditions
Explore the condition pages connected to this study.